Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
140,800
Employees140,800
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
140,800
Employees140,800

JNJ Key Statistics

Market cap
674.86B
Market cap674.86B
Price-Earnings ratio
28.97
Price-Earnings ratio28.97
Dividend yield
2.10%
Dividend yield2.10%
Average volume
9.14M
Average volume9.14M
High today
$269.50
High today$269.50
Low today
$264.79
Low today$264.79
Open price
$268.45
Open price$268.45
Volume
5.95M
Volume5.95M
52 Week high
$274.90
52 Week high$274.90
52 Week low
$164.23
52 Week low$164.23

Stock Snapshot

With a market cap of 674.86B, Johnson & Johnson(JNJ) trades at $265.65. The stock has a price-to-earnings ratio of 28.97 and currently yields dividends of 2.10%.

As of 2026-07-29, Johnson & Johnson(JNJ) stock has fluctuated between $264.79 and $269.50. The current price stands at $265.65, placing the stock +0.3% above today's low and -1.4% off the high.

The Johnson & Johnson(JNJ)'s current trading volume is 5.95M, compared to an average daily volume of 9.14M.

In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $274.90 and a 52-week low of $164.23.

In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $274.90 and a 52-week low of $164.23.

JNJ News

Reuters 5h
Explainer: Can J&J finally put the talc litigation behind it? - Reuters

...

Explainer: Can J&J finally put the talc litigation behind it? - Reuters
TipRanks 8h
Johnson & Johnson price target raised to $300 from $290 at Argus

Argus analyst David Toung raised the firm’s price target on Johnson & Johnson to $300 from $290 and keeps a Buy rating on the shares. The firm is citing the com...

Nasdaq 10h
Johnson & Johnson vs. Eli Lilly: Reliable Stability vs. Rapid Revenue Growth

Key Points Eli Lilly currently displays stronger upward momentum in top-line growth, whereas Johnson & Johnson maintains a higher but flatter overall baseline....

Johnson & Johnson vs. Eli Lilly: Reliable Stability vs. Rapid Revenue Growth

Analyst ratings

73%

of 26 ratings
Buy
73.1%
Hold
23.1%
Sell
3.8%

More JNJ News

Simply Wall St 14h
Johnson & Johnson Stock May Be 31% Below Fair Value On Talc Settlement

Johnson & Johnson stock has delivered a 76.0% return over the past five years, while a Discounted Cash Flow (DCF) intrinsic value estimate currently points to t...

Johnson & Johnson Stock May Be 31% Below Fair Value On Talc Settlement
24/7 Wall St. 21h
How a 44-Year-Old Could Build a $9,000 Monthly Paycheck by 60 Without Maxing a 401(k)

How a 44-Year-Old Could Build a $9,000 Monthly Paycheck by 60 Without Maxing a 401(k) By Michael Williams Published Jul 28, 8:28PM EDT Quick Read Generating $...

How a 44-Year-Old Could Build a $9,000 Monthly Paycheck by 60 Without Maxing a 401(k)
Nasdaq 24h
These 3 Companies Reported Record Results and Raised Guidance

The 2026 Q2 earnings cycle continues to roll along, with the reporting docket remaining stacked in the coming days and weeks. The period has been another one of...

These 3 Companies Reported Record Results and Raised Guidance
TipRanks 1d
Johnson & Johnson: Talc Settlement Progress Removes Major Overhang; Buy Rating Reiterated with Unchanged $282 Price Target

Johnson & Johnson, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Asad Haider from Goldman Sachs maintained a Buy rati...

Benzinga 1d
Johnson & Johnson Puts 15-Year Meritless Talc Litigation To Rest

The proposed resolution, coordinated with lead plaintiff firms in federal Multi-District Litigation (MDL) and state courts, requires a 95% participation rate am...

Johnson & Johnson Puts 15-Year Meritless Talc Litigation To Rest
TipRanks 1d
Johnson & Johnson Proposes Major Ovarian Talc Settlement

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...

Benzinga 1d
Stock Market Today: Dow Jones Futures Gain, Nasdaq 100 Declines as Oil Slips Ahead of Trump's Meetings With Zelensky and Netanyahu—Boeing, Coca-Cola, Johnson & Johnson in Focus

U.S. stock futures were mixed on Tuesday, as the Dow Jones index gained but the S&P 500 and Nasdaq 100 indices declined, following Monday’s mixed close. Meanwhi...

Stock Market Today: Dow Jones Futures Gain, Nasdaq 100 Declines as Oil Slips Ahead of Trump's Meetings With Zelensky and Netanyahu—Boeing, Coca-Cola, Johnson & Johnson in Focus

People also own

Based on the portfolios of people who own JNJ. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.